Current and completed investments

Sciety is specialised in growth companies within life science. We invest in biotechnology, digital health, ICT in healthcare, pharmaceuticals and medical technology.

Current investments

Receive information about upcoming investment opportunities

Sign up below to get information about upcoming investment opportunities and investor lunch meetings with the companies’ managements.

Completed investments

Sciety_Predicare-RETTS

Predicare

Predicare is the company behind the system RETTS©, used by 95% of Sweden’s hospitals and ambulances. RETTS© daily helps healthcare professionals to make the right decisions in emergency situations.

Single Technologies

The company has developed a DNA sequencing solution with significantly improved performance compared with current alternatives. The market is growing rapidly in terms of both research and clinical applications.

Lipigon Pharmaceuticals

Lipigon develops orphan drugs for illnesses due to disorders in how the body handles fat. The company’s major program, Lipsense, focuses on the illness, HoFH, where there is, today, no sufficient treatment.

Sciety_Cartana_NeuroKits

Cartana

Cartana’s patent-applied research tool revolutionises the possibility of analysing tissue samples, providing pharmaceutical companies with important information in their quest for new treatments.

Exits

Inhalation Sciences

Inhalation Sciences’ technology is used by prominent players within the chemical and pharma sectors to study how airborne particles impact the human body.

Attana

With Attana’s patented technology, pharmaceutical companies can evaluate, in an early development stage, how drug candidates impact the body and can identify the risk of side effects.

Raytelligence

Raytelligence has developed a unique, non-intrusive radar sensor and cloud platform for monitoring vital signs, such as respiration, heartbeat and position and movement. The company is aimed at elderly care in the home.

Liv Diagnostics

Tumor cell proliferation causes 90% of all cancer deaths. Liv Diagnostics is developing new technology to measure the spreading capacity of tumor cells and provide predictive information on the risk of metastasis.